Evidence map›Paper›PMID 38162787›Full record

ArticleACS omega2023

Deciphering the Role of H-Ferritin Nanocages in Improving Tumor-Targeted Delivery of Indocyanine Green: Combined Analysis of Murine Tissue Homogenates with UHPLC-MS/MS and Fluorescence.

Marta Sevieri, Cristina Sottani, Arianna Chesi, Arianna Bonizzi, Leopoldo Sitia, Francesco Saverio Robustelli Della Cuna, Elena Grignani, Fabio Corsi, Serena Mazzucchelli

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Marta SevieriNanomedicine Laboratory, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.
Cristina SottaniEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.
Arianna ChesiNanomedicine Laboratory, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.
Arianna BonizziNanomedicine Laboratory, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.
Leopoldo SitiaNanomedicine Laboratory, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.
Francesco Saverio Robustelli Della CunaEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.
Elena GrignaniEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.
Fabio CorsiNanomedicine Laboratory, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.
Serena MazzucchelliNanomedicine Laboratory, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.ORCID https://orcid.org/0000-0001-6904-8895
University of Milan · ITIstituti Clinici Scientifici Maugeri · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the relevance of encapsulation in H-ferritin nanocages (HFn) in determining an improved tumor-targeted delivery of indocyanine green (ICG). Since from previous experiments, the administration of HFn loaded with ICG (HFn-ICG) resulted in an increased fluorescence signal of ICG, our aim was to uncover if the nanoformulation could have a major role in driving a specific targeting of the dye to the tumor or rather a protective action on ICG's fluorescence. Here, we took advantage of a combined analysis involving ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) on murine tissue homogenates matched with fluorescence intensities analysis detected by ex vivo optical imaging. The quantification of ICG content performed on different organs over time combined with the fluorescent signal detection confirmed the superior delivery of ICG thanks to the nanoformulation. Our results showed that HFn-ICG drives a real accumulation at the tumor instead of only having a role in the preservation of ICG's fluorescence, further supporting its use as a delivery system of ICG for fluorescence-guided surgery applications in oncology.

Identifiers

PMID38162787
PMCPMC10753538
OpenAlexW4389580039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.